Published On: December 5th, 2019Tags: , ,

Share

Published On: December 5th, 2019Tags: , ,

Share

Our collaborator on the National Living Donor Assistance Center (NLDAC) project, Amit Mathur, MD, transplant surgeon at the Mayo Clinic of Arizona, has been selected to receive the prestigious 2020 Vanguard Award from the American Society of Transplant Surgeons (ASTS), in recognition of his recent publication in Clinical Transplantation, “Return on investment for financial assistance for living kidney donors in the United States.”  This work finds that financial support for organ donors’ out-of-pocket expenses produces dramatic federal savings through incremental living donor kidney transplants, by transitioning patients off dialysis.

Figure 2. from the paper.

Projected return on investment for living donor financial assistance relative to U.S. dialysis and transplant costs. ROI from the NLDAC program is calculated here based on federal spending for dialysis and kidney transplantation, with and without the NLDAC program costs. NLDAC costs are derived from the initial application accrual period and are held constant through the projections over time. In the first year, investment in NLDAC produces $48.2 million in savings, representing a 5.1-fold ROI overall. Notably, this ROI varied across states, from 3.9-fold to 6.6-fold. At 3 y, the ROI was 19-fold overall (state-state ROI IQR 14.0-23.0), producing $173.6 million in savings. At 5 y, NLDAC investment produces $256.4 in savings, representing a 28.2-fold return on investment, which ranged up to 34-fold at the 75th percentile of U.S. states.
This is an important finding in support of our long-term mission of making organ donation a net-zero endeavor for living donors.  Arbor Research co-authors on this manuscript include, Jiawei Xing, David Dickinson, and Bob Merion.
Citation
Mathur AK, Xing J, Dickinson DM, Warren PH, Gifford KA, Hong BA, Ojo AO, Merion RM. Return on investment for financial assistance for living kidney donors in the US. Clin Transplant. 2018;32(7):e13277.

Related Posts

  • Arbor Research Announces World Congress of Nephrology 2024 Presentations

    Arbor Research Collaborative for Health (Arbor Research), a leading provider of innovative solutions in healthcare research, is pleased to announce its participation in the upcoming World Congress of Nephrology (WCN) 2024, scheduled to take place from April 13th to 16th, 2024. The WCN 2024 conference, organized by the International Society of Nephrology (ISN), is a […]

  • Arbor Research Welcomes Steve Hines, PhD

    Arbor Research is pleased to announce the appointment of Dr. Steve Hines, PhD as a Senior Research Scientist focusing on health services research and strategic partnerships. Dr. Hines brings a wealth of experience and expertise, having most recently led learning community activities for the AHRQ-funded TAKEheart project while his work updating AHRQ’s TeamSTEPPS training curriculum […]

  • Arbor Research Celebrates World Kidney Day

    Advancing the scientific understanding of kidney disease to inform healthcare practice and policy is at the core of Arbor Research’s history.  Founded in 1996 in Ann Arbor, Michigan by three leaders in chronic kidney disease care and research, we were originally named the University Renal Research and Education Association (URREA). Arbor Research’s first project was […]

  • Trending Topics: DOPPS Alkaline Phosphatase and Parathyroid Hormone Levels

    The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program at Arbor Research Collaborative for Health is pleased to share their recent publication recognized as one of the most- downloaded articles at Kidney International Reports in the past few weeks titled “Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the […]